Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Relay Therapeutics Inc (NASDAQ: RLAY) was $6.74 for the day, down -4.53% from the previous closing price of $7.06. In other words, the price has decreased by -$4.53 from its previous closing price. On the day, 1.15 million shares were traded. RLAY stock price reached its highest trading level at $7.2 during the session, while it also had its lowest trading level at $6.61.
Ratios:
Our analysis of RLAY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 20.73 and its Current Ratio is at 20.73. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 19, 2023, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $29.
On April 13, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on April 13, 2023, with a $29 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 29 ’24 when Bergstrom Donald A sold 2,686 shares for $6.38 per share. The transaction valued at 17,137 led to the insider holds 527,427 shares of the business.
Catinazzo Thomas sold 1,695 shares of RLAY for $10,814 on Apr 29 ’24. The Chief Financial Officer now owns 339,803 shares after completing the transaction at $6.38 per share. On Apr 29 ’24, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 1,623 shares for $6.38 each. As a result, the insider received 10,355 and left with 325,767 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 894681024 and an Enterprise Value of 197376896. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.32 while its Price-to-Book (P/B) ratio in mrq is 1.20. Its current Enterprise Value per Revenue stands at 5.587 whereas that against EBITDA is -0.542.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $13.32, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is -14.01%, while the 200-Day Moving Average is calculated to be -25.94%.
Shares Statistics:
RLAY traded an average of 1.24M shares per day over the past three months and 1057080 shares per day over the past ten days. A total of 127.46M shares are outstanding, with a floating share count of 93.31M. Insiders hold about 29.70% of the company’s shares, while institutions hold 70.84% stake in the company. Shares short for RLAY as of 1713139200 were 10692091 with a Short Ratio of 8.65, compared to 1710460800 on 11812402. Therefore, it implies a Short% of Shares Outstanding of 10692091 and a Short% of Float of 10.39.
